To explore the effect of Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets in the treatment of unstable angina pectoris (UAP).
A total of 92 UAP patients in our hospital from August 2018 to August 2021 were randomly divided into observation group and control group, with 46 cases in each group. Both groups were given basic treatment, the control group was given arotinolol hydrochloride tablets, and the observation group was treated with Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets. Treatment effect was evaluated after 2 weeks of treatment. The incidence of adverse reactions during the treatment period was calculated. Angina pectoris were counted before treatment, 1 week and 2 weeks after treatment in the two groups. Heart function, oxidation-antioxidant indexes, stromal cell-derived factor-1 (SDF-1), chemokine receptor 7 (CXCR7) were measured.
The efficacy evaluation results of the two groups showed that the observation group was higher than the control group (P<0.05). After 1 and 2 weeks of treatment, angina pectoris frequency, duration, visual analog scale score and weekly nitroglycerin consumption in the observation group were lower than those in the control group, left ventricular ejection fraction, cardiac index, the blood transfusion volume per stroke in the observation group were higher than those in the control group (P<0.05). After 1 and 2 weeks of treatment, malondialdehyde, lipid peroxide, SDF-1, and CXCR7 in the observation group were lower than those in the control group, and superoxide dismutase was higher than that in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05).
Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets can alleviate angina pectoris attack in UAP patients, improve heart function, restore oxidation-antioxidant balance, regulate SDF-1 and CXCR7 with significant effects and high safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |